ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05310	Asthma	2/8	17/7206	0.000145472097576
ko05340	Primary immunodeficiency	2/8	30/7206	0.000461946924618
ko00600	Sphingolipid metabolism	2/8	63/7206	0.00203625998569
ko04664	Fc epsilon RI signaling pathway	2/8	77/7206	0.00302705733205
ko04071	Sphingolipid signaling pathway	2/8	162/7206	0.0128669115378
ko04611	Platelet activation	2/8	163/7206	0.0130194776299
ko04060	Cytokine-cytokine receptor interaction	2/8	191/7206	0.0176151079547
ko04072	Phospholipase D signaling pathway	2/8	197/7206	0.0186794601306
ko00592	alpha-Linolenic acid metabolism	1/8	19/7206	0.020909960907
ko00120	Primary bile acid biosynthesis	1/8	20/7206	0.0219998065049
ko00591	Linoleic acid metabolism	1/8	22/7206	0.0241763136784
ko05330	Allograft rejection	1/8	24/7206	0.0263485813954
ko00511	Other glycan degradation	1/8	26/7206	0.028516616736
ko05320	Autoimmune thyroid disease	1/8	29/7206	0.0317607495045
ko05166	HTLV-I infection	2/8	292/7206	0.0389784714968
ko04672	Intestinal immune network for IgA production	1/8	37/7206	0.0403654728365
ko00565	Ether lipid metabolism	1/8	42/7206	0.045709380268
ko05144	Malaria	1/8	45/7206	0.0489032104372